BRAMPTON, Ontario--(BUSINESS WIRE)--Taro Pharmaceuticals Inc. has initiated a voluntary Type 1 recall to the patient level on six (6) lots of Taro-Zoledronic Acid Injection, 5 mg/100 mL in 100 mL ...
Please provide your email address to receive an email when new articles are posted on . “Discontinuation of denosumab results in high-turnover bone loss and increased fracture risk,” Sabashini ...
Avenacy's zoledronic acid injection is available as a 4 mg/5 ml (0.8 mg per ml) single-dose vial. [Read more: Avenacy intros generic Reglan] Avenacy said that the medication will feature the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results